Clinical Trials Logo

Clinical Trial Summary

Mycoplasma pneumoniae pneumonia in children is one of the major diseases in children's respiratory department in China, but there are still large clinical unmet needs.


Clinical Trial Description

In order to further verify the clinical value and safety of Xiyanping injection in children with Mycoplasma pneumoniae pneumonia, to provide references for subsequent confirmatory research, and to provide more reasonable and standardized application guidance and basis for clinical practice, we intend to adopt more rigorous Scientific design to carry out a multi-center, randomized, double-blind, parallel-controlled study of Xiyanping injection in the treatment of children with Mycoplasma pneumoniae pneumonia. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04296383
Study type Interventional
Source Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Contact
Status Not yet recruiting
Phase N/A
Start date June 15, 2020
Completion date August 15, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06348095 - Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia N/A
Recruiting NCT02618057 - Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia Phase 4
Not yet recruiting NCT06325293 - A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study N/A
Completed NCT02303587 - Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP) N/A